Enoxaparin

See full prescribing information for dosing and administration information. 2.1 Pretreatment Evaluation Evaluate all patients for a bleeding disorder before starting enoxaparin sodium treatment, unless treatment is urgently needed. 2.2 Adult Dosage Abdominal Surgery The recommended dose of enoxaparin sodium is 40 mg by subcutaneous injection once a day (with the initial dose given 2 hours prior to surgery) in patients undergoing abdominal surgery who are at risk for thromboembolic complications.

Directions from the U.S. FDA-approved label — your doctor or pharmacist may advise differently.

Enoxaparin sodium injection is contraindicated in patients with: Active major bleeding, History of immune-mediated heparin-induced thrombocytopenia (HIT) within the past 100 days or in the presence of circulating antibodies, Known hypersensitivity to enoxaparin sodium (e.g., pruritus, urticaria, anaphylactic/ anaphylactoid reactions), Known hypersensitivity to heparin or pork products Active major bleeding History of heparin-induced thrombocytopenia (HIT) within the past 100 days or in the presence of circulating antibodies Hypersensitivity to enoxaparin sodium Hypersensitivity to heparin or pork products

Excerpt from the U.S. FDA-approved label. Talk to a pharmacist or doctor before use.

Increased risk of hemorrhage: Monitor for signs of bleeding Risk of Heparin-Induced Thrombocytopenia with or without Thrombosis Thrombocytopenia: Monitor platelet count closely Interchangeability with other heparins: Do not exchange with heparin or other LMWHs Increased Risk of Thrombosis in Pregnant women with Mechanical Prosthetic Heart Valves: women and their fetuses may be at increased risk. Monitor more frequently and adjust dosage as needed.

Warnings and precautions excerpt from the U.S. FDA-approved label — not a complete list. Talk to a pharmacist or doctor before use.

The following serious adverse reactions are also discussed in other sections of the labeling: Spinal/epidural hematomas, Increased Risk of Hemorrhage, Thrombocytopenia Most common adverse reactions (>1%) were bleeding, anemia, thrombocytopenia, elevation of serum aminotransferase, diarrhea, nausea, ecchymosis, fever, edema, peripheral edema, dyspnea, confusion, and injection site pain To report SUSPECTED ADVERSE REACTIONS,…

Excerpt from the U.S. FDA-approved label — not a complete list. Talk to a pharmacist or doctor about side effects.

196 products from 95 makers in the NepalDoc medicine catalog use this generic:

Showing 30 of 196 catalog products. Search the full catalog in the app.

Brand list from the NepalDoc medicine catalog. Availability varies by pharmacy — call ahead to confirm stock.

Store at 25°C (77°F);

Storage information from the U.S. FDA-approved label.